🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The purpose of this study is to document the immunological response to the ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00362336
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
The purpose of the study is to provide immunogenicity and safety data of th...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00401531
Primary Objective: * To demonstrate that the immune response of the DTaP-I...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00831311
Treatments Being Tested
To demonstrate that DTaP-IPV-HB-PRP\~T combined vaccine does not induce a h...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00313911
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01983540
This is a follow-up of Study A3L11 (NCT00404651). Immunogenicity * To des...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00654901
Primary objectives: To investigate the incidence of adverse events occurre...
Status
Completed
Location
Investigational Site Number : 002
Start Date
2025-01-17
Trial ID
NCT06793826
Treatments Being Tested
The study aims to confirm that, in Peruvian infants, the investigational DT...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT00831753
Treatments Being Tested